BIOPREDIC INTERNATIONAL SARL - France 

Ranking results:

Past rankings:

2019
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
2012
Criterium:Position:
Overall Score:900-1000
Total Project Funding per Partner:800-900
Total Number of Projects:70
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:46
Project Leadership Index:75
Diversity Index:60
2011
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
2007
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2010-01-01 - 2025-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 4
As coordinator: 0
As participant: 4
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2022 0 6.348.927 393.128 1
2019 0 6.761.834 243.750 1
2012 0 5.996.180 646.450 1
2011 0 4.849.981 168.237 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE2
KAROLINSKA INSTITUTE2
THE UNIVERSITY OF EDINBURGH2
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM1
AGENCE FRANCAISE DE SECURITE SANITAIRE DES ALIMENTS1
ANAXOMICS BIOTECH S L1
ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOCIENCIAS1
BILKENT UNIVERSITESI1
BRUNEL UNIVERSITY LONDON1
CAMBRIDGE CELL NETWORKS1
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE1
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS1
DEPARTMENT OF HEALTH1
DEUTSCHES FORSCHUNGSZENTRUM FUR KUNSTLICHE INTELLIGENZ1
EMULATE INC1
EUROPEAN RESEARCH AND PROJECT OFFICE1
FACULDADE DE FARMACIA DA UNIVERSIDADE DE LISBOA1
FORSCHUNGSGESELLSCHAFT FUR ARBEITSPHYSIOLOGIE UND ARBEITSSCHUTZ E V1
FUNDACIO PRIVADA CLINIC PER A LA RECERCA BIOMEDICA1
FUNDACION INSTITUTO DE INVESTIGACION MARQUES DE VALDECILLA1
FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSITARIO PUERTA DE HIERROMAJADAHONDA1
FUNDACION PUBLICA ANDALUZA PARA LA INVESTIGACION DE MALAGA EN BIOMEDICINA Y SALUD1
HEPART MEDICAL DEVICES BV1
HOFFMANN SEBASTIAN1
HOSPITAL CLINIC DE BARCELONA1
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE1
INSILICO BIOTECHNOLOGY1
INSTITUT NATIONAL DE RECHERCHE ENINFORMATIQUE ET AUTOMATIQUE1
INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE L'ALIMENTATION ET L'ENVIRONNEMENT1
IZMIR BIYOTIP VE GENOM MERKEZI1
LINKOPINGS UNIVERSITET1
PHARMACELL BV1
SERVICIO ANDALUZ DE SALUD1
SERVICIO CANTABRO DE SALUD1
SERVICIO MADRILENO DE SALUD1
STICHTING HET NEDERLANDS KANKER INSTITUUTANTONI VAN LEEUWENHOEK ZIEKENHUIS1
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA1
UMEA UNIVERSITET1
UNIVERSIDAD COMPLUTENSE DE MADRID1
UNIVERSIDAD DE MALAGA1
UNIVERSIDAD MIGUEL HERNANDEZ DE ELCHE1
UNIVERSIDADE NOVA DE LISBOA1
UNIVERSITAET DES SAARLANDES1
UNIVERSITE DE RENNES I1
UNIVERSITEIT MAASTRICHT1
UNIVERSITEIT UTRECHT1
UNIVERSITY OF CAMBRIDGE1
UNIVERSITY OF GLASGOW1
VLAAMSE INSTELLING VOOR TECHNOLOGISCH ONDERZOEK NV1
WEIZMANN INSTITUTE OF SCIENCE1

Constancy:

Total number of partners: 53
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 53
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2022-12-01Discovering chronic inflammation biomarkers that define key stages in the Healthy-to-NASH (non-alcoholic steatohepatitis) transition to inform early prevention and treatment strategies halt-RONINparticipant6.348.92723
2019-01-01Beating Goliath: Generation Of NoveL, Integrated and Internationally Harmonised Approaches for Testing Metabolism Disrupting Compounds GOLIATHparticipant6.761.83416
2012-06-01Development of a bioartificial liver therapy in acute liver failure BALANCEparticipant5.996.1805
2011-01-01Predicting long-term toxic effects using computer models based on systems characterization of organotypic cultures NOTOXparticipant4.849.98113

Alias institution names:

  • BIOPREDIC INTERNATIONAL SARL